Abbott (ABT) Q4 2024 Annual Earnings
ABT·Reported January 22, 2025·Before market open
Abbott reported Q4 2024 revenue of $11.0B, missed analyst consensus of $11.0B by $57.2M. Diluted EPS came in at $1.34. Abbott reports across 4 business segments, led by Medical Devices, Established Pharmaceutical Products, and Diagnostic Products.
Revenue
$11.0Bmissed by $57.2M
Consensus: $11.0BDiluted EPS
$1.34met estimate
Consensus: $1.34
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Abbott's Q4 2024 earnings report.
Abbott (ABT) reported Q4 2024 earnings on January 22, 2025 before market open.
Abbott reported revenue of $11.0B and diluted EPS of $1.34 for Q4 2024.
Revenue missed the consensus estimate of $11.0B by $57.2M. EPS beat the consensus estimate of $1.34 by $0.00.
You can read the 10-K periodic report (0001628280-25-007110) directly on SEC EDGAR. The filing index links above go to sec.gov.